163 related articles for article (PubMed ID: 34294620)
1. 5-HT
Ochi S; Mori T; Iga JI; Ueno SI
Clin Psychopharmacol Neurosci; 2021 Aug; 19(3):514-520. PubMed ID: 34294620
[TBL] [Abstract][Full Text] [Related]
2. A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.
Sato S; Mizukami K; Asada T
Int J Neuropsychopharmacol; 2007 Apr; 10(2):281-3. PubMed ID: 16817981
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of behavioural and psychological symptoms of dementia in cognitively impaired elderly residents of long-term care facilities in East Asia: a cross-sectional study.
Makimoto K; Kang Y; Kobayashi S; Liao XY; Panuthai S; Sung HC; Suzuki M; Terada S; Yamakawa M
Psychogeriatrics; 2019 Mar; 19(2):171-180. PubMed ID: 30394003
[TBL] [Abstract][Full Text] [Related]
4. The association between circadian rest-activity patterns and the behavioral and psychological symptoms depending on the cognitive status in Japanese nursing-home residents.
Saito Y; Kume Y; Kodama A; Sato K; Yasuba M
Chronobiol Int; 2018 Nov; 35(12):1670-1679. PubMed ID: 30102089
[TBL] [Abstract][Full Text] [Related]
5. [Behavioral and psychological symptoms in elderly people with cognitive impairment. Differences between assessment at home and at an adult day-care facility].
Hashidate H; Harada K; Asakawa Y; Yamagami T; Nihei K; Kaneya S; Yoshii C
Nihon Koshu Eisei Zasshi; 2012 Aug; 59(8):532-43. PubMed ID: 23066632
[TBL] [Abstract][Full Text] [Related]
6. Sleep disturbances are key symptoms of very early stage Alzheimer disease with behavioral and psychological symptoms: a Japan multi-center cross-sectional study (J-BIRD).
Kabeshita Y; Adachi H; Matsushita M; Kanemoto H; Sato S; Suzuki Y; Yoshiyama K; Shimomura T; Yoshida T; Shimizu H; Matsumoto T; Mori T; Kashibayashi T; Tanaka H; Hatada Y; Hashimoto M; Nishio Y; Komori K; Tanaka T; Yokoyama K; Tanimukai S; Ikeda M; Takeda M; Mori E; Kudo T; Kazui H
Int J Geriatr Psychiatry; 2017 Feb; 32(2):222-230. PubMed ID: 27001907
[TBL] [Abstract][Full Text] [Related]
7. Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study.
Lin J; Su Y; Wang C; Yang F; Xu Y; Yuan Y; Yuan Y; Wang X; Yu X; Si T
J Psychiatr Res; 2018 Apr; 99():104-110. PubMed ID: 29433063
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of differences in behavioral and psychological symptoms of dementia in nursing home residents in Sydney and Shanghai.
Wu HZ; Low LF; Xiao S; Brodaty H
Int Psychogeriatr; 2009 Jun; 21(3):476-84. PubMed ID: 19257917
[TBL] [Abstract][Full Text] [Related]
9. Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia.
Hsu TJ; Tsai HT; Hwang AC; Chen LY; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():28-35. PubMed ID: 28436192
[TBL] [Abstract][Full Text] [Related]
10. Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
Rainer MK; Mucke HA; Krüger-Rainer C; Haushofer M; Kasper S
CNS Drugs; 2004; 18(1):49-55. PubMed ID: 14731059
[TBL] [Abstract][Full Text] [Related]
11. Development of a Thai tool for assessing behavioral and psychological symptoms of dementia: A confirmatory factor analysis.
Phannarus H; Muangpaisan W; Siritipakorn P; Pianchob S; Supapueng O
Brain Behav; 2020 Nov; 10(11):e01816. PubMed ID: 32857486
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia.
Wang CS; Cheng KS; Tang CH; Pai MC; Chen PL; Chien PF
Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):701-714. PubMed ID: 36263645
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric Inventory in Community-Dwelling Older Adults with Mild Cognitive Impairment and Dementia.
Nunes PV; Schwarzer MC; Leite REP; Ferretti-Rebustini REL; Pasqualucci CA; Nitrini R; Rodriguez RD; Nascimento CF; Oliveira KC; Grinberg LT; Jacob-Filho W; Lafer B; Suemoto CK
J Alzheimers Dis; 2019; 68(2):669-678. PubMed ID: 30856109
[TBL] [Abstract][Full Text] [Related]
15. Elder-Clowning in Long-Term Dementia Care: Results of a Pilot Study.
Kontos P; Miller KL; Colobong R; Palma Lazgare LI; Binns M; Low LF; Surr C; Naglie G
J Am Geriatr Soc; 2016 Feb; 64(2):347-53. PubMed ID: 26889843
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.
Rainer M; Haushofer M; Pfolz H; Struhal C; Wick W
Eur Psychiatry; 2007 Sep; 22(6):395-403. PubMed ID: 17482432
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Dementia Severity and Behavioral and Psychological Symptoms of Dementia in Dementia with Lewy Bodies and Alzheimer's Disease Patients.
Hashimoto M; Yatabe Y; Ishikawa T; Fukuhara R; Kaneda K; Honda K; Yuki S; Ogawa Y; Imamura T; Kazui H; Kamimura N; Shinagawa S; Mizukami K; Mori E; Ikeda M
Dement Geriatr Cogn Dis Extra; 2015; 5(2):244-52. PubMed ID: 26195980
[TBL] [Abstract][Full Text] [Related]
18. Open-label, observational study of the effects of risperidone on the behavioral and psychological symptoms of dementia and caregiver stress in the community setting.
Arriola E; Ignacio Diago J; Antonio Burón J; Gallego R;
Am J Geriatr Pharmacother; 2005 Mar; 3(1):8-16. PubMed ID: 16089242
[TBL] [Abstract][Full Text] [Related]
19. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study.
Cummings JL; Koumaras B; Chen M; Mirski D;
Am J Geriatr Pharmacother; 2005 Sep; 3(3):137-48. PubMed ID: 16257816
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.
Murata Y; Yanagihara Y; Mori M; Mine K; Enjoji M
J Affect Disord; 2015 Jul; 180():1-9. PubMed ID: 25879718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
